Efficacy and Safety of SJP-0132 in Patients With Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study.

Hori Y, Wada T, Omatsu K, SJP-0132 clinical study investigators

Open source

DOI
10.1016/j.ajo.2025.11.036
Published
2026 Mar
Container
American journal of ophthalmology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ajo.2025.11.036,
  title = {Efficacy and Safety of SJP-0132 in Patients With Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study.},
  author = {Hori Y and Wada T and Omatsu K and SJP-0132 clinical study investigators},
  year = {2026},
  journal = {American journal of ophthalmology},
  doi = {10.1016/j.ajo.2025.11.036},
  url = {https://doi.org/10.1016/j.ajo.2025.11.036}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of SJP-0132 in Patients With Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study.
AU  - Hori Y
AU  - Wada T
AU  - Omatsu K
AU  - SJP-0132 clinical study investigators
PY  - 2026
JO  - American journal of ophthalmology
DO  - 10.1016/j.ajo.2025.11.036
UR  - https://doi.org/10.1016/j.ajo.2025.11.036
ER  - 

APA

Y, H., T, W., K, O., & investigators, S. C. S. (2026). Efficacy and Safety of SJP-0132 in Patients With Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study.. American journal of ophthalmology. https://doi.org/10.1016/j.ajo.2025.11.036

Source records